High Tower Advisors, LLC Atai Life Sciences N.V. Transaction History
High Tower Advisors, LLC
- $71.6 Billion
- Q4 2024
A detailed history of High Tower Advisors, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, High Tower Advisors, LLC holds 30,462 shares of ATAI stock, worth $70,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,462
Previous 30,352
0.36%
Holding current value
$70,062
Previous $35,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ATAI
# of Institutions
101Shares Held
14.8MCall Options Held
168KPut Options Held
77.9K-
Morgan Stanley New York, NY3.33MShares$7.66 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$4.46 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$3.01 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$2.26 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$2.18 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $382M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...